Hydroxyamphetamine Hydrobromide and Tropicamide Ophthalmic Solution
Last Updated: April 25, 2017
- Akorn had Paremyd on shortage due to manufacturing delays.
- No clinical trial data were found to support the use of Paremyd in the diagnosis of Horner Syndrome.
- Paremyd ophthalmic solution, Akorn, 1% hydroxyamphetamine hydrobromide and 0.25% tropicamide, 15 mL bottle, 1 count, NDC 17478-0704-12
Estimated Resupply Dates
- Akorn has Paremyd ophthalmic solution available.
Updated April 25, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Created July 13, 2015 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.